Certara, Inc. CERT

Full chart Compare
Set alert

Price alert · CERT

All alert types
10.87 USD +0.16 (+1.49%)

At closeNov 3, 2026, 4:00 PM EST

10.87 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

10.46 Day range 11.02
4.45 52-week range 11.88
YTD
+23.38%
1 year
-7.09%
Market cap
1.66B
Revenue (ttm)
421.75M
Profit margin
-16.22%
EPS (ttm)
-0.14
Shares out
152.54M
Forward P/E
27.77
YTD return
+23.38%
1-year return
-7.09%
Volume
1.87M
Avg volume
2.76M
Open
10.58
Previous close
10.71
Day's range
10.46 – 11.02
52-week range
4.45 – 11.88
Beta
1.25
Analysts
Buy
Price target
9.17 (-15.7%)
Earnings date
Nov 5, 2026

5D -0.10 (-0.91%)

1111.50WedThuFriMon10.94

Key statistics

Enterprise value
1.75B
PEG ratio
0.00
Price / sales
3.93
Price / book
1.72
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
1.00%
Free cash flow
62.58M
Total cash
184.87M
Total debt
301.94M
Return on equity
-2.21%
Short % of float
26.37%
50-day average
9.06
200-day average
7.27

Financials — quick view

All financials
CERT Revenue — quarterly 93.27M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CERT Net income — quarterly -55.27M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CERT EPS — quarterly -0.36
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

CERT recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Sep 30, 20260.08656———
Aug 4, 2026Jun 30, 20260.08930.08-0.01-10.41%
May 11, 2026Mar 31, 20260.110.09-0.02-18.18%
Feb 26, 2026Dec 31, 20250.110.09-0.02-18.18%
Nov 6, 2025Sep 30, 20250.110.14+0.03+27.27%
Aug 6, 2025Jun 30, 20250.100.07-0.03-30.00%

Upgrades / downgrades

CERT analyst upgrades and downgrades
DateFirmActionFromTo
Oct 16, 2026KeybancmainOverweightOverweight
Oct 13, 2026TD CowenmainBuyBuy
Oct 7, 2026BarclaysmainEqual-WeightEqual-Weight
Sep 30, 2026UBSdownBuyNeutral
Aug 5, 2026BarclaysmainEqual-WeightEqual-Weight
May 12, 2026Craig-HallummainHoldHold

About Certara, Inc.

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. It also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix cloud that offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration that supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform; Certara D360 software, a scientific informatics system; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and writes regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.

Sector
Healthcare
Industry
Health Information Services
Country
United States
Website
certara.com

News

Your note

Sign in to keep a note on CERT — it syncs with the Stock Master app.

Insider holders

CERT insider holders
InsiderRelationLatest transactionDateShares held
ASPBURY ROBERTOfficerConversion of Exercise of derivative securityMar 31, 2026332,442
BROSHY ERANChairman of the BoardConversion of Exercise of derivative securityMay 13, 202650,708
CASHMAN JAMES E IIIChairman of the BoardConversion of Exercise of derivative securityMay 13, 2026484,197
COLLINS CYNTHIADirectorConversion of Exercise of derivative securityMay 13, 202651,846
CRANE ROSEMARY ADirectorConversion of Exercise of derivative securityMay 13, 202645,672
FEEHERY WILLIAM F.Chief Executive OfficerPurchaseNov 10, 20252,360,770

Institution ownership

CERT institution ownership
Holder% heldSharesValueReported
Blackrock Inc.12.34%18,818,180204.55MJun 29, 2026
Deerfield Management Company, L.P4.93%7,512,92881.67MJun 29, 2026
Haveli Investment Management LLC4.85%7,400,00080.44MJun 29, 2026
Jefferies Financial Group Inc.4.65%7,091,05177.08MJun 29, 2026
Vanguard Portfolio Management LLC4.63%7,056,10676.70MJun 29, 2026
Dimensional Fund Advisors LP3.95%6,022,68665.47MJun 29, 2026

Fund ownership

CERT fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF4.40%6,716,94073.01MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.44%3,721,80540.46MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.01%3,060,35733.27MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.75%2,673,18629.06MJun 29, 2026
Touchstone Strategic TRT-Touchstone Strategic TRT-Touchstone Small Com1.44%2,195,40723.86MJun 29, 2026
WASATCH FUNDS TRUST-Wasatch Small Cap Value Fund1.19%1,814,40619.72MJun 29, 2026